Bringing the fundamentals into focus…
Back to Myriad Genetics, Inc.
How Myriad Genetics, Inc. stacks up
MYGN · against 431 other Healthcare companies of similar size
Growth
38/ 100
Below the middle of the pack.
Ranked #225 of 432 · scores higher than 47% of peers
Bars: peers in each 10-point band of the growth score50 peers with a growth score of 30–39, including MYGN · Click a bar to see the companies
Why growth scores 38?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth, which is weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 73% of peers. Revenue growth: -1.6% vs peer median 6.1%
- Earnings per share growth is not reported, so it is left out of the score.
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 6.7% vs peer median 5.8%
Metric by metric
Position: dot = MYGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MYGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 446 reported | -1.6% | 3.2% | 36% | 33% | |
| Earnings per share growthHigher is better · 225 reported | Not reported | 3.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 424 reported | 6.7% | 3.5% | 62% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around MYGN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 221 | 964M EUR (≈$1.1B) | 39 | 58 | |
| 221 | 16.2B THB (≈$453M) | 39 | 63 | |
| 225 | 6.4B HKD (≈$821M) | 38 | 54 | |
| 225 | 357M USD | 38 | 32 | |
| 225 | 578M USD | 38 | 22 | |
| 225 | 30.4B INR (≈$365M) | 38 | 39 | |
| 229 | 3.9B CNY (≈$540M) | 37 | 71 | |
| 229 | 2.7B CNY (≈$383M) | 37 | 51 | |
| 229 | 6.9B CNY (≈$967M) | 37 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score